Pfizer's Phase III renal cell carcinoma trial fails to meet primary endpoint

Pfizer&#39s Phase III renal cell carcinoma trial fails to meet major endpoint
The mixture of bevacizumab and IFN-alpha-2a is authorized as first-line treatment for advanced RCC and clinical supplies of both of these drugs in this trial were provided through an agreement with Roche. … The inhibition of mTOR also reduces …
Study far more on

Study reveals optimal remedy for most frequent infection following organ
To compare these strategies, Tomas Reischig, MD, PhD (Charles University Medical School and Teaching Hospital, in Pilsen, Czech Republic) and his colleagues assigned kidney transplant recipients—who either had CMV present in their blood or who …
Study a lot more on Health-related Xpress

Patient &#39refused treatment&#39
A PATIENT with kidney cancer was allegedly turned away at Helen Joseph Hospital in Johannesburg by a medical doctor who told him to get his personal remedy worth R50.000 just before he could be operated on. Unemployed Thato Mofokeng, 22, of Tsepisong close to …
Study much more on Sowetan